FTPP, or Adipotide is a peptide which has the possibility to decrease fat. The most important query is can FTPP lose fat, based on how it works the response comes true. FTPP is designed to deliver apoptosis, or programmed cell death of fat cells as it targets the blood vessels that supply white adipose tissue. One study performed on obese rhesus monkeys showed a decrease in fat mass by 11% after one month of treatment which again demonstrates the suckling ability to target excess fats.
Fate reduction by FTPP isn't about just shrinking the fat cells, it kills them entirely thus offering a gourdgeus advantage against traditional weight loss strategies like diet and exercise. Most traditional methods cause fat cell size to decrease, but there is no change in the number of fat cells (no wonder it can be so difficult for people to keep weight off). In contrast, FTPP mediated fat cell death may offer a more lasting solution to decrease of FX.
What FTPP did was similar to the advancement in the medical field through out history: from treating symptoms, it found a way of hitting on root causes. Developing targeted cancer therapies, for example stopped therapy and new treatment attacks the blood supply to tumors. Like FTPP, this cuts off circulation to fat cells causing them to die. A Dr at the Mayo Clinic talks about this approach and how it represents a major paradigm change in fat loss.
In order to fully untap the potential of FTPP, clinical trials and research will be necessary. Although the data in animal models show great benefits, human trials are needed to determine safety and long-term efficacy of FTPP. This was evident in the monkey experiments, where as well as losing fat they acquired increased insulin sensitivity which is perhaps a more relevant point regarding type II diabetes. These results indicated that FTPP displayed an anti-adipogenic effect, and therefore had a potential metabolic health beneficial function.
Nonetheless, the downsides to FTPP are something we should look at carefully. Initial studies suggest kidney failure may be a side effect and, therefore, monitoring is critical as this metabolite develops further in clinical trials. As with any new treatment, its advantages need to be balanced by the risks. But the medical community is hesitant about it, pointing out that plenty of more research and investigation on a large scale for FTP-1487 required.
Overall, when it comes to FTPP there is good theoretical potential for great effect in fat retraction considering the capacity of directly inducing apoptosis between adipocytes. Although this effect has not been seen in humans, similar studies have shown Nootkatone to help reduce body fat by as much as 11% over a one month period. But more studies are needed to fully explore its effects on human health Patients who want to know more about the FTPP need to talk with their physician in order understand what are possible advantages and disadvantages of such a procedure.